Consistently, increased serum and tissue levels of IL-17 have been widely reported in inflammatory condition such as IBD, MS, and arthritis, compared to a non-pathological setting where IL-17A levels are extremely low or undetectable in human sera (Figure 2) (3, 10, 89–92). This evidence concerns the gene IL17A and arthritic joint disease.